CODE ON DISCLOSURE OF TRANSFERS OF VALUE FROM PHARMACEUTICAL COMPANIES TO HEALTHCARE PROFESSIONALS AND HEALTHCARE ORGANISATIONS

Friday, 27 May 2016

The following Disclosure code sets out disclosures of payments and other transfers of value to healthcare professionals, whether directly or indirectly via healthcare organisations.

CODE ON THE INFORMING AND COMMUNICATION OF PRESCRIPTION-ONLY MEDICINES TO, AND COOPERATION WITH, HEALTHCARE PROFESSIONALS

Friday, 27 May 2016

The HCP code regulates the promotion of prescription-only medicinal products to healthcare professionals.

CODE OF PRACTICE ON RELATIONSHIPS BETWEEN THE PHARMACEUTICAL INDUSTRY AND PATIENT ASSOCIATIONS

Thursday, 8 March 2012

The FORUM encourages competition among pharmaceutical companies. The FORUM Code is not intended to restrain the promotion of medicinal products in a manner that is detrimental to fair competition. Instead, it seeks to ensure that pharmaceutical companies conduct such promotion in a truthful manner, avoiding deceptive practices and potential conflicts of interest with healthcare professionals, and in compliance with applicable laws and regulations. The FORUM Code thereby aims to foster an environment where the general public can be confident that choices regarding their medicines are being made on the basis of the merits of each product and the healthcare needs of patients.